» Articles » PMID: 14665959

Suppression of Detrusor-sphincter Dyssynergia by Immunoneutralization of Nerve Growth Factor in Lumbosacral Spinal Cord in Spinal Cord Injured Rats

Overview
Journal J Urol
Publisher Wolters Kluwer
Specialty Urology
Date 2003 Dec 11
PMID 14665959
Citations 50
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: We investigated the effects of intrathecal application of nerve growth factor (NGF) antibodies (NGF-Abs) and desensitization of C-fiber afferent pathways by capsaicin treatment on detrusor-sphincter dyssynergia (DSD) after spinal cord injury (SCI).

Materials And Methods: In adult female rats SCI was induced by complete transection of the spinal cord at Th8 to 9. Ten days after spinalization vehicle or NGF-Ab (10 microg daily) was continuously administered at the level of the L6-S1 spinal cord through an implanted intrathecal catheter connected to an osmotic pump for 2 weeks. Another group of spinalized rats was treated with capsaicin (125 mg/kg subcutaneously) 3 weeks after spinalization and 5 days before experiments. Simultaneous recordings of intravesical pressure and urethral perfusion pressure were then performed. NGF levels in the L6 spinal cord were measured in vehicle or NGF-Ab treated spinalized rats using enzyme-linked immunosorbent assay.

Results: DSD was observed in all vehicle treated spinalized rats. The average urethral pressure increase at the peak bladder contraction was significantly lower by 84% and 78% in NGF-Ab and capsaicin treated spinalized rats, respectively, than in vehicle treated rats. After NGF-Ab treatment NGF levels were significantly decreased by 38% in the L6 spinal cord compared with vehicle treated spinalized rats, in which NGF levels in the L6 spinal cord were 7 times higher than in spinal intact rats.

Conclusions: Increased levels of NGF in the spinal cord could contribute to the emergence of DSD that is at least in part mediated by C-fiber bladder afferents after SCI. Thus suppression of NGF levels in afferent pathways could be useful for treating DSD following SCI.

Citing Articles

Assessing Neurogenic Lower Urinary Tract Dysfunction after Spinal Cord Injury: Animal Models in Preclinical Neuro-Urology Research.

Doelman A, Streijger F, Majerus S, Damaser M, Kwon B Biomedicines. 2023; 11(6).

PMID: 37371634 PMC: 10294962. DOI: 10.3390/biomedicines11061539.


Molecular Mechanisms of Neurogenic Lower Urinary Tract Dysfunction after Spinal Cord Injury.

Shimizu N, Saito T, Wada N, Hashimoto M, Shimizu T, Kwon J Int J Mol Sci. 2023; 24(9).

PMID: 37175592 PMC: 10177842. DOI: 10.3390/ijms24097885.


Therapeutic effects of p38 mitogen-activated protein kinase inhibition on hyperexcitability of capsaicin sensitive bladder afferent neurons in mice with spinal cord injury.

Suzuki T, Shimizu T, Karnup S, Shimizu N, Ni J, de Groat W Life Sci. 2023; 325:121738.

PMID: 37121541 PMC: 10225342. DOI: 10.1016/j.lfs.2023.121738.


Consequences of spinal cord injury on the sympathetic nervous system.

Wulf M, Tom V Front Cell Neurosci. 2023; 17:999253.

PMID: 36925966 PMC: 10011113. DOI: 10.3389/fncel.2023.999253.


Molecular Mechanism Operating in Animal Models of Neurogenic Detrusor Overactivity: A Systematic Review Focusing on Bladder Dysfunction of Neurogenic Origin.

Ferreira A, Nascimento D, Cruz C Int J Mol Sci. 2023; 24(4).

PMID: 36834694 PMC: 9959149. DOI: 10.3390/ijms24043273.